<SEC-DOCUMENT>0001143313-23-000114-index.html : 20231023 <SEC-HEADER>0001143313-23-000114.hdr.sgml : 20231023 <ACCEPTANCE-DATETIME>20231023135624 ACCESSION NUMBER: 0001143313-23-000114 CONFORMED SUBMISSION TYPE: 25-NSE PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20231023 DATE AS OF CHANGE: 20231023 EFFECTIVENESS DATE: 20231023 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: NAVIDEA BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000810509 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 311080091 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 25-NSE SEC ACT: 1934 Act SEC FILE NUMBER: 000-26520 FILM NUMBER: 231339680 BUSINESS ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 BUSINESS PHONE: 6147937500 MAIL ADDRESS: STREET 1: 4995 BRADENTON AVENUE STREET 2: SUITE 240 CITY: DUBLIN STATE: OH ZIP: 43017 FORMER COMPANY: FORMER CONFORMED NAME: NEOPROBE CORP DATE OF NAME CHANGE: 19940714 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NYSE AMERICAN LLC CENTRAL INDEX KEY: 0001143313 IRS NUMBER: 522127241 FILING VALUES: FORM TYPE: 25-NSE BUSINESS ADDRESS: STREET 1: 11 Wall Street CITY: New York STATE: NY ZIP: 10005 BUSINESS PHONE: 212-656-5414 MAIL ADDRESS: STREET 1: 11 Wall Street CITY: New York STATE: NY ZIP: 10005 FORMER COMPANY: FORMER CONFORMED NAME: NYSE MKT LLC DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: NYSE Amex DATE OF NAME CHANGE: 20090402 FORMER COMPANY: FORMER CONFORMED NAME: NYSE Alternext US LLC DATE OF NAME CHANGE: 20081009 </SEC-HEADER> <DOCUMENT> <TYPE>25-NSE <SEQUENCE>1 <FILENAME>primary_doc.xml <TEXT> Document 1 - file: primary_doc.html
Document 1 - RAW XML: primary_doc.xml
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.25 <SEQUENCE>2 <FILENAME>ruleprovisionnotice.htm <TEXT> Document 2 - file: ruleprovisionnotice.htm
</DOCUMENT> </SEC-DOCUMENT>